Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "NIPER-Hajipur"

2 News Found

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
Policy | April 25, 2026

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration

The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.

Latest Stories

Vision 360 brings academia, industry together to advance ophthalmic therapies

DSS Imagetech to host webinar series on advanced imaging technologies

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Director Bioprocessing–IMEA, Avantor
Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Director Bioprocessing–IMEA, Avantor
Ganesh Bade Director Bioprocessing–IMEA, Avantor
We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
Saurav Kasera Founder, CLIRNET
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Packaging